Log in to search using one of your social media accounts:

This page shows you the latest items in this publication.

FDA Links Breast Implants To Cases Of Rare Blood Cancer
The agency announced that at least nine women have died from a form of non-Hodgkin ' s lymphoma associated with the surgery. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Janet Burns, Women at Forbes Source Type: news

FDA Agrees With WHO, Links Breast Implants To Rare Cancer. How Worried Should Women Be?
The FDA now agrees with the WHO that a rare type of lymphoma is linked to breast implants, especially those with a textured surface. However, the agency doesn ' t recommend that worried women have their implants removed to be on the safe side. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Source Type: news

How One Nonprofit Is Bringing Attention To World Water Day
663 million people worldwide lack access to safe, clean water. But the nonprofit Charity: Water is trying to fix that. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Sarah Hedgecock, Forbes Staff Source Type: news

How Mobile Apps Reduce Follow-Up Visits After Surgery
A mobile app reduced the need for “in-person” visits to a doctor following breast reconstructive surgery without “affecting complication rates or patient satisfaction,” research in JAMA Surgery said. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:UNH NYSE:WLP NYSE:CI NYSE:AET Source Type: news

Lawmakers Want To Start Crowdfunding Rape Kit Tests
In response to nationwide backlogs, state legislators are turning to residents to ensure the cost of testing evidence won ' t get in the way of justice. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Janet Burns, Women at Forbes Source Type: news

In Search Of Votes, GOP Makes Changes To Plan To Repeal & Replace Obamacare
The GOP ' s plan to repeal and replace Obamacare has been met with criticism, so in an effort to win votes, Congress went back to work. The new proposal has a number of changes that could affect taxpayers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Kelly Phillips Erb, Forbes Staff Source Type: news

The AHCA ' s Tax Changes And Transfers Would Benefit The Wealthy, Hurt The Lowest Income Households
The AHCA would benefit the wealthy, while low-income households would be worse off than today. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Howard Gleckman, Contributor Source Type: news

Report: U.S. Projected To Face A Serious Shortfall In Doctors [Infographic]
A new report from the Association of American Medical Colleges (AAMC) has predicted that the U.S will face a shortfall of tens of thousands of doctors between now and 2030. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Niall McCarthy, Contributor Source Type: news

Not All Cardiologists Trust Amgen ' s Cholesterol Drug Study
Outcome studies such as these are among the riskiest in pharmaceutical R&D. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NYSE:PFE NASDAQ:AMGN Source Type: news

These High-Profile U.S. Exports To China Growing Too Fast For Trade War, As Trump And Xi Near Meeting
At President Trump prepares to meet next month with Chinese President Xi, a closer look at high-profile, fast-growing U.S. exports to China, from aircraft to pork, motor vehicles to makeup. While U.S. exports have fallen 1.94 percent over the last five years, they have grown 11.19 percent to China. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Ken Roberts, Contributor Tags: DJIA:BA Source Type: news

These High-Profile U.S. Exports To China Growing Too Fast For Trade War, As Trump-Xi Near Meeting
At President Trump prepares to meet next month with Chinese President Xi, a closer look at high-profile, fast-growing U.S. exports to China, from aircraft to pork, motor vehicles to makeup. While U.S. exports have fallen 1.94 percent over the last five years, they have grown 11.19 percent to China. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 22, 2017 Category: Pharmaceuticals Authors: Ken Roberts, Contributor Tags: DJIA:BA Source Type: news

Foreign Patent Rights May Be In Trouble As Supreme Court Mulls Printer-Cartridge Case
Supreme Court justices sound skeptical about giving U.S. patent owners the right to keep their products from returning home. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2017 Category: Pharmaceuticals Authors: Daniel Fisher, Forbes Staff Tags: NYSE:LXK NASD:QCOM Source Type: news

Health Insurance Lobby Backs Key Trumpcare Revisions
America ' s Health Insurance Plans gave support to Trumpcare ' s reforms to the individual insurance market where millions of uninsured buy subsidized policies on public exchanges. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:UNH NYSE:CNC NYSE:AET NYSE:HUM NYSE:CI Source Type: news

Supreme Court Eliminates Delay Defense In Patent Cases
The Supreme Court eliminates a defense against patent suits based on delay. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2017 Category: Pharmaceuticals Authors: Daniel Fisher, Forbes Staff Tags: OTC:SVCBY Source Type: news

GOP House ' s Revised Trumpcare Would Speed Medicaid Cuts
Revisions to GOP House legislation to replace the Affordable Care Act would still leave millions of Americans without healthcare coverage, hit hospitals hard financially and make states kick in more costs. That ' s too much for liberals and not enough for conservatives. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:CYH NYSE:THC NYSE:HCA Source Type: news

Pregnant Women Need DHA -- But Diet Beats Supplements
Omega-3 fatty acids are undoubtedly important nutrients for a developing fetus, but DHA supplements may not help much. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2017 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

InMed Pharmaceuticals Is More Than Just Another Cannabis Drug Company
It may be too soon to compare InMed Pharmaceutical to GW Pharmaceutical, but this pre-clinical biotech company has lot more going on than its drug pipeline. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2017 Category: Pharmaceuticals Authors: Debra Borchardt, Contributor Tags: OTC:IMLFF NYSE:GWPH Source Type: news

Why Biotech ' s Talent, Capital And Returns Are Consolidating Into Two Key Clusters
Boston and San Francisco have become the dominant biotech clusters; in recent years, startups in these regions have consolidated an increasing share of the capital and talent in the ecosystem. Author reviews the data and discusses a set of implications. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2017 Category: Pharmaceuticals Authors: Bruce Booth, Contributor Source Type: news

Health Spending Projections By CMS Could Influence AHCA Votes
Although there are many assessments about the second attempt of AHCA, there is also updated health spending and usage data from CMS. And those numbers are important for predicting what our national health costs might look like in the coming years, and how we need to think about health care. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2017 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Source Type: news

Anti-PCSK9 Drugs: An Ingenious Solution for a Problem That ' s Mostly Already Solved
Antibodies against PCSK9 point to the future of drug discovery. Unfortunately, in the decade it has taken to bring them to market, the problem they were designed to solve has mostly been solved with cheaper approaches. Great science will bring only a modest amount of clinical benefit. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: David Grainger, Contributor Source Type: news

Hubble Contacts Wants To Do For Contact Lenses What Harry ' s Did For Razors
Hubble Contacts founders Ben Cogan, 27, and Jesse Horwitz, 28, are trying to shake up the contact lens industry with $30/month, Instagram-friendly daily lenses by subscription. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Amy Feldman, Forbes Staff Tags: NYSE:JNJ NYSE:VRX Source Type: news

Smiling Is Not A Universal Sign Of Happiness, According To Modern Neuroscience
" Emotions are whole-brain affairs, " Lisa Feldman Barrett writes on the theory of " constructed emotion. " (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Katherine Love, Forbes Staff Source Type: news

State AGs Probe Asbestos Bankruptcy Trusts To Recover Medicare Payments
Republican AGs borrow a page from their liberal colleagues and sue asbestos trusts for information about money they paid to Medicare and Medicaid beneficiaries. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Daniel Fisher, Forbes Staff Tags: NYSE:GM NYSE:HUM NYSE:HON Source Type: news

3D Systems Is Offering A Scalable 3D-Printing System For Manufacturers
3D Systems has a new platform for 3D printing that permits full-scale manufacturing - and its first products may wind up in your dentists ' office. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Source Type: news

Man Draws $4.3M IRS Penalty For Lending $100K To Struggling Business
Payroll tax liabilities can be personal, with a 100% IRS penalty on all ' responsible persons. ' You don ' t want to be one. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Robert W. Wood, Contributor Tags: NYSE:HRB NASDAQ:INTU Source Type: news

Trump Wants To Kill Biomedical Research. This Is Cruel And Pointless
Trump ' s proposed budget will cut NIH by 20%, devastating biomedical research and damaging the long-term health of the nation. It only reduces the budget by 0.15%. This is short-sighted, heartless, and just (to be blunt) stupid. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Steven Salzberg, Contributor Source Type: news

How Trumpcare Gets In The Way Of Doctors Accepting Medicaid
A little more than half, or 53% of physicians in 15 large U.S. metropolitan areas accept Medicaid patients among five frequently used specialties, according to a new survey (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:UNH NYSE:HUM NYSE:WLP NYSE:AET NYSE:CI Source Type: news

Congress And Trump Are Competing For The Most Destructive Budget Award -- And We All Lose
Recent budget proposals include shocking cuts to programs supporting our historical core values of caring for each other, instead promoting " autonomy, " more tax breaks for the wealthiest, and huge military investments. How will this #MAGA? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Judy Stone, Contributor Source Type: news

Esperion Therapeutics Sees Clear FDA Path For Its Heart Drug
Esperion Therapeutics says the Food and Drug Administration has agreed that the company ' s medicine, bempadoic acid, could be approved based on blood test results, before a larger study proving it prevents heart attacks, strokes, heart procedures or deaths has been completed. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:ESPR NASDAQ:MDCO NASDAQ:AMGN Source Type: news

CIO Tom Miller Drives $85B Anthem ' s Innovation Studio
Tom Miller has gone from Sales and general management roles early in his career to IT leadership for the past couple of decades. He is now the CIO of $85 billion Anthem, and his latest move has been to stand up the Anthem Innovation Studio to help the company disrupt itself. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Peter High, Contributor Tags: NYSE:KO NYSE:ANTM NYSE:IT Source Type: news

Compassion Must Drive Healthcare Policy
The CBO report shows current legislation to repeal and replace the ACA falls short of lowering health insurance costs and providing health insurance for everybody, and does not adequately address the needs of all the nation ’s citizens. This could put hospitals in perilous financial circumstances. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Kenneth L. Davis, Contributor Source Type: news

The Tweet That Caused A Seizure: How Twitter Was Weaponized
When Kurt Eichenwald, a senior writer at Newsweek, publicly disclosed that he suffered from epilepsy, little did he imagine someone sending a tweet as an online weapon--a GIF image of a strobe light--to provoke a seizure. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Robert Glatter, MD, Contributor Source Type: news

CEO Exits At China Billionaire ' s Fledging Evergrande Health
Real estate developer bought the business in 2015 in search of healthcare growth (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2017 Category: Pharmaceuticals Authors: Russell Flannery, Forbes Staff Source Type: news

Stop Wasting Doctors ' Time And Resources By Overtesting Them
The number of tests that doctors have to take has gotten out of control. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 19, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Study: Whole-Body Vibration May Reduce Weight Like Running On A Treadmill, But...
Can standing on a vibrating platform really replace more vigorous exercise? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 19, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Study: Whole Body Vibration May Reduce Weight Like Running On A Treadmill But...
Can standing on a vibrating platform really replace more vigorous exercise? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 19, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Doctor Wait Times Soar 30% In Major U.S. Cities
Patients are waiting an average of 24 days to schedule an appointment for a doctor, an increase of 30% from 2014, according to a study of appointments for commonly used specialty physicians in 15 major U.S. cities by Merritt Hawkins. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 19, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:WLP NYSE:AET NYSE:CI NYSE:UNH Source Type: news

Cities With The Longest Wait Time To See A Doctor
(Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 19, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:WLP NYSE:AET NYSE:CI NYSE:UNH Source Type: news

Doctor Wait Times Soar Amid Trumpcare Debate
Patients are waiting an average of 24 days to schedule an appointment for a doctor, an increase of 30% from 2014, according to a study of appointments for commonly used specialty physicians in 15 major U.S. cities by Merritt Hawkins. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 19, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:WLP NYSE:AET NYSE:CI NYSE:UNH Source Type: news

Don ' t Just Bet On Luck To Avoid a Stroke
iRhythm ' s single-use patch is innovative approach to ambulatory cardiac monitoring (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 19, 2017 Category: Pharmaceuticals Authors: Gene Marcial, Contributor Source Type: news

Bill Gates Is Right: USAID Is Not Just Foreign Aid, It Aids The U.S.
Trump ' s proposed cuts of the USAID budget will affect Americans in many ways. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 18, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Bill Gates Is Right, USAID Is Not Just Foreign Aid, It Aids The U.S.
Trump ' s proposed cuts of the USAID budget will affect Americans in many ways. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 18, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

The New Wonder Woman Movie Trailer And The Battle Over Her Armpits
They did what to Gal Gadot ' s armpits? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 18, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Tom Price ' s Liver And ' The Coverage They Want '
Secretary Price, the Purple Healthcare Plan is a great option. Take a read before repeating that we ' ll all be able to purchase the healthcare we want. We all want full coverage. Under your healthcare " reform, " what tens of millions of Americans will be able and choose to purchase is zero coverage. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 17, 2017 Category: Pharmaceuticals Authors: Laurence Kotlikoff, Contributor Source Type: news

An Inside View From Nine Months On The Campaign Trail With President Trump
At Forbes and Shook Research ' s inaugural Top Advisors Summit in Las Vegas, Anthony Scaramucci gave an inside vied of his nine months on the campaign trail and assured managers of $1 trillion in assets that tax reform can still come by August. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 17, 2017 Category: Pharmaceuticals Authors: Antoine Gara, Forbes Staff Source Type: news

The Consumer Supply Chain: Evolving Under the Long Shadow of The 3G Effect
The evolution of supply chain processes under the dark cloud of the 3G Effect. Leaders beware! (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 17, 2017 Category: Pharmaceuticals Authors: Lora Cecere, Contributor Source Type: news

The Most Powerful Personality Trait You May Never Have Heard Of
The trait known as intellectual humility may be the most important one —from your personal life to politics. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 17, 2017 Category: Pharmaceuticals Authors: Alice G. Walton, Contributor Source Type: news

Why Improving Population Health Makes Financial Sense
When you think that only 10% of health outcomes are a result of the clinical care a person receives, you start thinking differently about what is needed to improve population health. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 17, 2017 Category: Pharmaceuticals Authors: Science Business, Contributor Tags: NYSE:HUM Source Type: news

With Trial Results, Should Amgen Reconsider Its Pricing For Repatha?
The cost of Repatha is about $14,000/year. Is it worth it? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 17, 2017 Category: Pharmaceuticals Authors: Harlan Krumholz, Contributor Source Type: news

With Trial Results, Amgen Should Reconsider Its Pricing For Repatha
The cost of Repatha is about $14,000/year. Is it worth it? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 17, 2017 Category: Pharmaceuticals Authors: Harlan Krumholz, Contributor Source Type: news